Valuation: Allmed Solutions Ltd

Capitalization 34.91M 0 11.76M 9.96M 9.17M 8.67M 16.08M 1.09B 16.36M 107M 42.09M 527M 44.11M 43.19M 1.86B P/E ratio 2024
-3.66x
P/E ratio 2025 -2.14x
Enterprise value 6.41M 0 2.16M 1.83M 1.68M 1.59M 2.95M 200M 3M 19.7M 7.72M 96.8M 8.1M 7.93M 341M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
63.87%
Yield 2024 *
-
Yield 2025 -
1 week-4.38%
Current month-1.97%
1 month-7.43%
3 months+2.95%
6 months+10.44%
Current year+8.72%
1 week 34.8
Extreme 34.8
36.6
1 month 33.4
Extreme 33.4
37.7
Current year 31.4
Extreme 31.4
40.5
1 year 27.9
Extreme 27.9
40.5
3 years 26.1
Extreme 26.1
47.5
5 years 24.2
Extreme 24.2
94.9
10 years 24.2
Extreme 24.2
175
Manager TitleAgeSince
Chief Executive Officer 70 01/03/2022
Director of Finance/CFO - 01/12/2021
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 70 -
Director/Board Member 56 22/10/2019
Director/Board Member 57 03/08/2022
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-4.38%+17.91%+29.26% 11.65M
+1.30%+0.94%-1.20%+16.93% 130B
+1.28%+1.72%+28.91%+5.80% 14.46B
+3.61%+8.12%+39.43%+156.99% 7.06B
-1.06%+1.08%-37.57%-71.22% 5.12B
-0.77%+3.01%+32.03%+16.44% 2.63B
-1.80%-1.48%-12.07%-27.78% 1.93B
-1.83%-2.11%+14.34%-21.74% 1.78B
+1.33%+5.94%-61.90%-78.48% 1.63B
Average +0.20%+0.36%+2.21%+2.91% 18.25B
Weighted average by Cap. +1.18%+0.13%+2.04%+17.33%

Financials

2024 2025
Net sales - -
Net income -8.75M -0 -2.95M -2.5M -2.3M -2.17M -4.03M -273M -4.1M -26.91M -10.55M -132M -11.06M -10.83M -466M -14.12M -0 -4.76M -4.03M -3.71M -3.51M -6.5M -440M -6.62M -43.43M -17.03M -213M -17.85M -17.48M -752M
Net Debt -42.56M -0 -14.34M -12.14M -11.17M -10.58M -19.6M -1.33B -19.94M -131M -51.32M -643M -53.78M -52.66M -2.27B -28.5M -0 -9.6M -8.13M -7.48M -7.08M -13.13M -888M -13.36M -87.64M -34.37M -431M -36.02M -35.27M -1.52B
Logo Allmed Solutions Ltd
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
Employees
22
Date Price Change Volume
17/04/26 34.90 ILa 0.00% 10
15/04/26 34.90 ILa -4.38% 33,493
14/04/26 36.50 ILa 0.00% 16,921
13/04/26 36.50 ILa +1.96% 47,500